A 29-year-old woman, G2P1, is RhD negative and delivers an RhD-positive infant at term. There was no antepartum bleeding and no anti-D antibodies were detected during pregnancy. According to Canadian guidelines, what is the most appropriate postpartum management to prevent alloimmunisation?